Enspectra Health
Enspectra Health is a medical technology company pioneering digital dermatology with its first-in-class handheld cross-modal imaging technology. Their flagship product, the VIO system, combines multiphoton laser scanning and reflectance confocal microscopy to noninvasively generate high-resolution digital images of live skin cells in real time. This AI-powered platform provides dermatologists with actionable cellular insights at the point of care, enabling advanced, patient-centric skin health management without the need for incisions or biopsies. The company has achieved FDA clearance and breakthrough device designation, positioning it as a transformative player in skin cancer detection and broader skin condition evaluation. Enspectra Health operates with a leadership team experienced in optics, medical devices, and digital health commercialization, targeting dermatologists and healthcare providers to improve skin disease diagnosis and treatment.
Enspectra Health
Enspectra Health is a medical technology company pioneering digital dermatology with its first-in-class handheld cross-modal imaging technology. Their flagship product, the VIO system, combines multiphoton laser scanning and reflectance confocal microscopy to noninvasively generate high-resolution digital images of live skin cells in real time. This AI-powered platform provides dermatologists with actionable cellular insights at the point of care, enabling advanced, patient-centric skin health management without the need for incisions or biopsies. The company has achieved FDA clearance and breakthrough device designation, positioning it as a transformative player in skin cancer detection and broader skin condition evaluation. Enspectra Health operates with a leadership team experienced in optics, medical devices, and digital health commercialization, targeting dermatologists and healthcare providers to improve skin disease diagnosis and treatment.
TL;DR
Product: Handheld cross-modal skin imaging system (VIO / VisiScope) for noninvasive cellular-level imaging
Regulatory: FDA 510(k) clearance (VisiScope)
Funding: Has received NIH grant funding (Mar 2022, $1.2M) and total reported funding ~$12.05M
Headquarters: Mountain View / Redwood City (San Mateo County), California
Company Overview
Problem Domain
Dermatology diagnostics and skin disease monitoring (noninvasive cellular imaging / virtual biopsy).
Industry
Medical devices / Digital dermatology
Funding Track Record
1,200,000.00
NIH grant recorded March 2022